January 2023
1. LIN F, Yao Q, Yu B, Deng Z, et al
   The Efficacy and Safety of Teprotumumab in Thyroid Eye Disease: Evidence from Randomized Controlled Trials.
   Int J Clin Pract. 2023;2023:6638089.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share